The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: Postoperative course and long-term outcome

Annals of Surgical Oncology

Volumn 16, Issue 10, 2009, Pages 2744-2751

  Brouquet, Antoine ^a   Goéré, Diane ^a   Lefèvre, Jérémie H ^a   Bonnet, Stéphane ^a   Dumont, Frédéric ^a   Raynard, Bruno ^a   Elias, Dominique ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; RINGER LACTATE SOLUTION; ANTINEOPLASTIC AGENT;

ABDOMINAL ABSCESS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOID; CLINICAL ARTICLE; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LAPAROTOMY; LONG TERM CARE; MALE; MESOTHELIOMA; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEAL CARCINOMATOSIS; PERITONEUM METASTASIS; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; REOPERATION; SURGICAL TECHNIQUE; SURVIVAL RATE; CANCER STAGING; COLORECTAL TUMOR; FEASIBILITY STUDY; FOLLOW UP; INTRAPERITONEAL DRUG ADMINISTRATION; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM TUMOR; POSTOPERATIVE PERIOD; PROGNOSIS; REGIONAL PERFUSION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOID TUMOR; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; PSEUDOMYXOMA PERITONEI; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 73349134321     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0611-5     Document Type: Article

References (29)

1. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospec-tive study. Cancer. 2000;88:358-63.
2. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcino-matosis from colorectal cancer. Br J Surg. 2002;89:1545-50.
3. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal che-motherapy. Cancer. 2001;92:71-6.
4. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyper-thermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis ofcolorectal cancer. J Clin Oncol. 2003;21:3737-43.
5. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with per-ioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-insti-tutional study. J Clin Oncol. 2004;22:3284-92.
6. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24:4011-19.
7. Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomato-sis of colorectal origin. J Clin Oncol. 2009;27:681-5.
8. Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL. Cyto-reductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neo-plasms. BrJSurg. 2006;93:1270-6.
9. Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperito-neal chemotherapy. Br J Surg. 2008;95:1164-71.
10. Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with periop-erative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18:827-34.
11. Elias D, Bedard V, Bouzid T, Duvillard P, Kohneh-Sharhi N, Raynard B, et al. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemo-therapy. Gastroenterol Clin Biol. 2007;31:784-8.
12. Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560-67.
13. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. CancerRes. 1990;50:5790-4.
14. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intra-peritoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790-6.
15. Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11:375-9.
16. Bijelic L, Yan TD, Sugarbaker PH. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol. 2008;98:295-9.
17. Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2006;13:229-37.
18. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytore-ductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104-9.
19. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management. Boston MA: Kluwer Academic Publishers; 1996. p. 359-74.
20. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221: 29-42.
21. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727-31.
22. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
23. Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of per-itoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597-603.
24. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperther-mic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis ofcolorectal cancer. Ann Surg Oncol. 2008;15:2426-32.
25. Elias D, Lasser P, Hoang JM, Leclere J, Debaene B, Bognel C, et al. Repeat hepatectomy for cancer. BrJSurg. 1993;80:1557-62.
26. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Aba-scal A, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225:51-60.
27. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindi-cation to liver resection for multiple colorectal metastases? Ann Surg. 2004;240:1052-61.
28. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gush-chin V, Esquivel J, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intra-peritoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13: 635-44.
29. Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdom-inal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863-9.